Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 7/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.35 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.32 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21911826 | 0.79 | GAA (0.41) | ALDH1A1PKMP2RX3 | |
| SCHEMBL24939872 | 0.78 | ALDH1A1 (0.47) | ALDH1A1PKMAPAF1POLBLMNA | |
| SCHEMBL24939871 | 0.77 | LMNA (0.39) | ALDH1A1APAF1POLBLMNACYP1A2 | |
| SCHEMBL13459842 | 0.77 | CA12 (0.55) | ALDH1A1LMNA | |
| SCHEMBL24939870 | 0.76 | APAF1 (0.41) | ALDH1A1PKMAPAF1POLBLMNA | |
| SCHEMBL20969053 | 0.75 | ALDH1A1 (0.43) | ALDH1A1PKMAPAF1POLBLMNA | |
| SCHEMBL7165635 | 0.75 | APAF1 (0.43) | ALDH1A1APAF1POLBLMNACYP1A2 | |
| SCHEMBL15977327 | 0.75 | ALDH1A1 (0.41) | ALDH1A1PKMPOLBLMNA | |
| SCHEMBL6516911 | 0.71 | APAF1 (0.45) | ALDH1A1APAF1POLBLMNACYP1A2 | |
| SCHEMBL7462959 | 0.69 | ALDH1A1 (0.61) | ALDH1A1PKMPOLBLMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022129-A1 | RESIST MATERIAL AND PATTERNING PROCESS | GFER, LBR, PCNA | ALDH1A1 3757/4885PKM 3080/4885APAF1 4348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.